The Mechanisms of Apoptosis in Biology and Medicine: A New Focus for Ophthalmology

Abstract

Defects in apoptosis (programmed cell death) have recently emerged as being closely involved in the pathogenesis of most ocular diseases and, therefore, apoptosis is now a topic of exponential interest in ophthalmology. This review summarizes recent works on mechanisms of apoptosis, from its initiation and modulation to the switching-on of its execution machinery. Interactions of cell death with cell division programs to orchestrate ontogenesis, aging, and adult life and their alterations in human diseases are pointed out. Two main apoptotic signaling pathways are identified: a death receptor-dependent (extrinsic) pathway and a mitochondrion-dependent (intrinsic) pathway. Mitochondrion harbors both anti-apoptotic (Bcl-2, Bcl-X_L) and apoptotic factors (Smac/Diablo, Apaf-1, cytochrome c). Its permeability transition pore (mPTP) is the main trigger of cell suicide. The process of mPTP opening, in association with extrusion to cytoplasm of a variety of apoptotic factors, is shown. Cytochrome c is one of these apoptotic factors. When expelled to cytoplasm, this double-faced respiratory chain component assembles with two other modules, Apaf-1 and procaspase 9, to form a protein complex – the apoptosome – that starts apoptosis execution. Another respiratory chain component, the CoQ₁₀, is believed to counteract mPTP opening. What makes apoptosis particularly exciting for medicine is that its dysfunctions play a central role in the pathogenesis of several human diseases. For instance, excesses of apoptosis lead to cell loss that accompanies neurodegenerative diseases, whereas genetically determined defects of apoptosis lead to the deregulated cell proliferation typical of cancer. A variety of ophthalmologic diseases, such as post-keratectomy haze, corneal lesions, cataract, glaucoma, senile maculopathies, and genetic ocular pathologies, that underlie apoptosis dysfunctions are treated in detail in the other reviews of this issue.

Keywords

Apoptosis Ocular pathology Post-keratectomy haze Gene expression

Get full access to this article

View all access options for this article.

References

Meier

Finch

Evan

. Apoptosis in development. Nature 2000; 407: 796–801.

Higamy

Shimikawa

. Apoptosis in the aging process. Cell Tissue Res 2000; 1: 125–32.

Warner

H.R.

. Apoptosis: a two-edged sword in aging. Ann N Y Acad Sci 1999; 887: 1–11.

Zhang

Herman

. Ageing and apoptosis. Mech Ageing Develop 2002; 123: 245–60.

Vaux

D.L.

Korsmeyer

S.J.

. Cell death in development. Cell 1999; 96: 245–54.

DeLong

M.J.

. Apoptosis: a modulator of cellular homeostasis and disease states. Ann N Y Acad Sci 1998; 842: 82–90.

Ferri

K.F.

Kroemer

. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001; 3: E255–63.

Lindquist

Craig

E.A.

. The heat-shock proteins. Annu Rev Genet 1988; 22: 631–77.

Beere

H.M.

Green

D.R.

. Stress management – heat shock protein-70 and the regulation of apoptosis. Trends Cell Biol 2001; 11: 6–10.

10.

Xanthoudakis

Nicholson

D.W.

. Heat-shock proteins as death determinants. Nat Cell Biol 2000; 2: E163–5.

11.

Herr

Debatin

K-M

. Cellular stress response and apoptosis in cancer. Blood 2001; 98: 2603–14.

12.

Hengartner

M.O.

. The biochemistry of apoptosis. Nature 2001; 407: 770–6.

13.

Roy

Nicholson

D.W.

. Cross-talk in cell death signalling. J Exp Med 2000; 192: F21–5.

14.

Thornberry

N.A.

Lazebnik

. Caspases: enemies within. Science 1998; 281: 1312–6.

15.

Nicholson

D.W.

. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999; 6: 1028–42.

16.

Wilson

M.R.

. Apoptosis: unmasking the executioner. Cell Death Differ 1998; 5: 646–52.

17.

Wang

Lenardo

M.J.

. Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J Cell Sci 2000; 113: 753–7.

18.

Andrieu-Abadie

Gouazé

Salvayre

Levade

. Ceramide in apoptosis signaling: relationship with oxidative stress. Free Rad Biol Med 2001; 31: 717–28.

19.

Desagher

Martinou

J.C.

. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000; 10: 369–77.

20.

Wang

. The expanding role of mitochondria in apoptosis. Genes Dev 2001; 15: 2922–33.

21.

Jiang

Moriarty

S.E.

Grossniklaus

Nelson

K.C.

Jones

D.P.

Sternberg

Jr. . Increased oxidant-induced apoptosis in cultured nondividing human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2002; 43: 2546–53.

22.

Kluck

R.M.

Bossy-Wetzel

Green

D.R.

Newmeyer

D.D.

. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132–36.

23.

Crompton

. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999; 341: 233–49.

24.

De Giorgi

Lartigue

Bauer

M.K.

The permeability transition pore signals apoptosis by directing Bax translocation and multimerization.

FASEB J 2002; 16: 607–9.

25.

Fontaine

Ichas

Bernardi

. A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J Biol Chem 1998; 273: 25734–40.

26.

Brancato

Schiavone

Siano

Prevention of corneal keratocyte apoptosis after argon fluoride excimer laser irradiation with the free radical scavenger ubiquinone Q10.

Eur J Ophtalmol 2000; 10: 32–8.

27.

Brancato

Fiore

Papucci

Concomitant effect of topical ubiquinone Q10 and vitamin E to prevent keratocyte apoptosis after excimer laser photoablation in rabbits.

J Refract Surg 2002; 18: 135–9.

28.

Brancato

Papucci

Lapucci

Ubiquinone Q10 counteracts apoptotic signals unrelated to free radical production in cultured keratocytes.

Invest Ophthalmol Vis Sci 2001; 42(Suppl): S904.

29.

Schiavone

Rosini

Quattrone

A conserved AU-rich element in the 3′ untraslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis.

FASEB J 2000; 14: 174–84.

30.

Donnini

Lapucci

Papucci

Apoptosis is associated with modifications of bcl-2 mRNA AU-binding proteins.

Biochem Biophys Res Commun 2001; 287: 1063–9.

31.

Lapucci

Donnini

Papucci

AUF1 is a bcl-2 A+U-rich element-binding protein involved in bcl-2 mRNA destabilization during apoptosis.

J Biol Chem 2002; 3: 16139–46.

32.

Thompson

C.B.

. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456–62.

33.

Robertson

J.D.

Fadeel

Zhivotovsky

Orrenius

. Centennial Nobel Conference on apoptosis and human disease. Cell Death Differ 2002; 9: 468–75.

34.

Evan

G.I.

Vousden

K.H.

. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411: 342–8.

35.

Zhang

Schlossman

S.F.

Edwards

R.A.

C.N.

M.X.

. Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice. Proc Natl Acad Sci U S A 2002; 99: 878–83.

36.

Hayashi

Faustman

D.L.

. Implications of altered apoptosis in diabetes mellitus and autoimmune diseases. Apoptosis 2001; 6: 31–45.

37.

Rathmell

J.C.

Thompson

C.B.

. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 2002; 109(Suppl): S97–107.

38.

Dispersyn

G.D.

Borgers

. Apoptosis in the heart: about programmed cell death and survival. News Physiol Sci 2001; 16: 41–7.

39.

Gill

Mestril

Samali

. Losing heart: the role of apoptosis in heart disease-a novel therapeutic target? FASEB J 2002; 16: 135–46.

40.

Mallat

Tedgui

. Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res 2001; 88: 988–1003.

41.

Sykes

T.C.

Morris

A.G.

Bradbury

A.W.

Mosquera

. Apoptosis in vascular disease. Eur J Vasc Endovasc Surg 2001; 22: 389–95.

42.

Van Everbroeck

Dewulf

Pals

Lubke

Martin

J.J.

Cras

. The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol Aging 2002; 23: 59–64.

43.

Shimohama

. Apoptosis in Alzheimer's disease—an update. Apoptosis 2000; 5: 9–16.

44.

Roth

K.A.

. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol 2001; 60: 829–38.

45.

Behl

. Apoptosis and Alzheimer's disease. J Neural Transm 2000; 107: 1325–44.

46.

Hartmann

Hirsch

E.C.

. Parkinson's disease. The apoptosis hypothesis revisited. Adv Neurol 2001; 86: 143–53.

47.

Toubi

Kessel

Goldstein

Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity.

J Hepatol 2001; 35: 774–80.

48.

Casey

C.A.

Nanji

Cederbaum

A.I.

Adachi

Takahashi

. Alcoholic liver disease and apoptosis. Alcohol Clin Exp Res 2001; 25(Suppl): S49–53.

49.

Rust

Gores

G.J.

. Apoptosis and liver disease. Am J Med 2000; 108: 567–74.

50.

Schuchmann

Galle

P.R.

. Apoptosis in liver disease. Eur J Gastroenterol Hepatol 2001; 13: 785–90.

51.

Khan

Cleveland

R.P.

Koch

C.J.

Schelling

J.R.

. Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. Lab Invest 1999; 79: 1089–99.